Bisgaard H C, Santoni-Rugiu E, Nagy P, Thorgeirsson S S
Department of Life Sciences and Chemistry (HCB), Roskilde University, Denmark.
Lab Invest. 1998 Mar;78(3):237-46.
The proteolytic cascade involving plasminogen activators and plasmin appears to have an important function in tissue regeneration. We have investigated the expression and cellular localization of urokinase-type plasminogen activator (uPA), tissue-type plasminogen activator (tPA), urokinase-type plasminogen activator receptor (uPAR), and plasminogen activator inhibitor-1 (PAI-1) as well as plasminogen activation in rat liver regeneration by recruitment of progenitor (oval) cells. Using a model in which surgical partial hepatectomy is combined with feeding of 2-acetylaminofluorene (2-AAF) to induce liver regeneration by proliferation and differentiation of oval cells, expression of uPA, uPAR, and PAI-1 was detected by immunohistochemistry mainly in the duct-like formations of expanding oval cells. Plasminogen activation, as assessed by direct zymography on frozen liver sections, was located over the expanding oval cell populations but not over mature hepatocytes. Plasminogen activation was not detected in control liver. Expression of uPA, uPAR, and PAI-1, as assessed by immunohistochemical and Northern blot analyses, was also observed, when cells located in and in close proximity to the bile epithelial structures were activated to enter DNA-synthesis in response to 2-AAF, and after in vivo infusion of various growth factors. Given the physiologic function of plasminogen activation in fibrinolysis, and plasminogen activators in activation of latent growth factors, the selective expression of the plasminogen activator/plasmin proteolytic cascade in oval cells expanding during liver regeneration in response to the combination of 2-AAF and partial hepatectomy, may confer a proliferative advantage to these cell populations in an extracellular matrix containing both fibrin and latent growth factors.
涉及纤溶酶原激活剂和纤溶酶的蛋白水解级联反应似乎在组织再生中具有重要作用。我们通过募集祖细胞(卵圆细胞),研究了尿激酶型纤溶酶原激活剂(uPA)、组织型纤溶酶原激活剂(tPA)、尿激酶型纤溶酶原激活剂受体(uPAR)、纤溶酶原激活剂抑制剂-1(PAI-1)的表达及细胞定位,以及大鼠肝脏再生过程中的纤溶酶原激活情况。利用手术部分肝切除联合给予2-乙酰氨基芴(2-AAF)以通过卵圆细胞增殖和分化诱导肝脏再生的模型,通过免疫组织化学检测发现uPA、uPAR和PAI-1主要在扩张的卵圆细胞的导管样结构中表达。通过对冰冻肝脏切片进行直接酶谱分析评估的纤溶酶原激活,位于扩张的卵圆细胞群上,而不在成熟肝细胞上。在对照肝脏中未检测到纤溶酶原激活。当位于胆管上皮结构内及附近的细胞因2-AAF而被激活进入DNA合成时,以及在体内输注各种生长因子后,通过免疫组织化学和Northern印迹分析评估,也观察到了uPA、uPAR和PAI-1的表达。鉴于纤溶酶原激活在纤维蛋白溶解中的生理功能,以及纤溶酶原激活剂在激活潜在生长因子中的作用,在2-AAF和部分肝切除联合作用下肝脏再生过程中扩张的卵圆细胞中纤溶酶原激活剂/纤溶酶蛋白水解级联反应的选择性表达,可能赋予这些细胞群在含有纤维蛋白和潜在生长因子的细胞外基质中增殖的优势。